NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
19.56
-0.50 (-2.49%)
Nov 2, 2026, 4:00 PM EST - Market closed
NAMS Market Cap
NAMS has a market cap or net worth of $2.34 billion as of November 2, 2026. It is the 5,819th most valuable company in the world and the 1,653rd biggest in the United States. Its market cap has decreased by 45.30% in one year.
Market Cap
2.34B
Enterprise Value
1.66B
1-Year Change
-45.30%
Global Rank
Country Rank
#1,653 United States
Category
ChartMarket Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $2.34B, an increase of 1,413.86%. That is a compound annual growth rate of 60.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 2.34B | -41.22% |
| Dec 31, 2025 | 3.98B | 44.58% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arcus Biosciences | 2.62B |
| ADMA Biologics | 2.56B |
| Precigen | 2.48B |
| Recursion Pharmaceuticals | 2.41B |
| Celldex Therapeutics | 2.36B |
| Pharvaris | 2.35B |
| Biohaven | 2.33B |
| Harmony Biosciences Holdings | 2.26B |